BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37380755)

  • 21. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
    Maher JC; Wangpaichitr M; Savaraj N; Kurtoglu M; Lampidis TJ
    Mol Cancer Ther; 2007 Feb; 6(2):732-41. PubMed ID: 17308069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.
    Malm SW; Hanke NT; Gill A; Carbajal L; Baker AF
    J Exp Clin Cancer Res; 2015 Apr; 34(1):31. PubMed ID: 25888489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy.
    Wu H; Zhu H; Liu DX; Niu TK; Ren X; Patel R; Hait WN; Yang JM
    Cancer Res; 2009 Mar; 69(6):2453-60. PubMed ID: 19244119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capsaicin induces redox imbalance and ferroptosis through ACSL4/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells.
    Hacioglu C; Kar F
    Metab Brain Dis; 2023 Feb; 38(2):393-408. PubMed ID: 35438378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells.
    Kurtoglu M; Maher JC; Lampidis TJ
    Antioxid Redox Signal; 2007 Sep; 9(9):1383-90. PubMed ID: 17627467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
    Maschek G; Savaraj N; Priebe W; Braunschweiger P; Hamilton K; Tidmarsh GF; De Young LR; Lampidis TJ
    Cancer Res; 2004 Jan; 64(1):31-4. PubMed ID: 14729604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS; Adhikari JS; Jain V
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells.
    Hacioglu C; Kar F; Davran F; Tuncer C
    Environ Toxicol; 2023 Jul; 38(7):1690-1701. PubMed ID: 36988300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
    Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
    Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis.
    Xin Q; Lv W; Xu Y; Luo Y; Zhao C; Wang B; Yuan M; Li H; Song X; Jing T
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010618. PubMed ID: 35849619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth.
    Ralser M; Wamelink MM; Struys EA; Joppich C; Krobitsch S; Jakobs C; Lehrach H
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17807-11. PubMed ID: 19004802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polarization of macrophages towards M1 phenotype by a combination of 2-deoxy-d-glucose and radiation: Implications for tumor therapy.
    Farooque A; Afrin F; Adhikari JS; Dwarakanath BS
    Immunobiology; 2016 Feb; 221(2):269-81. PubMed ID: 26597503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.
    Dwarakanath BS; Singh D; Banerji AK; Sarin R; Venkataramana NK; Jalali R; Vishwanath PN; Mohanti BK; Tripathi RP; Kalia VK; Jain V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S21-6. PubMed ID: 20009289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma.
    Kawata M; Ogi K; Nishiyama K; Miyamoto S; Nakagaki T; Shimanishi M; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2017 Nov; 46(10):979-985. PubMed ID: 28640935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose.
    Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A
    Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic increase in efficacy of a combination of 2-deoxy-D-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis.
    Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S
    Tumour Biol; 2016 Sep; 37(9):12347-12358. PubMed ID: 27306214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway.
    Chen H; Wen J
    Eur J Pharmacol; 2022 Apr; 921():174860. PubMed ID: 35278406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
    Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells.
    Bhardwaj R; Sharma PK; Jadon SP; Varshney R
    Tumour Biol; 2012 Aug; 33(4):1021-30. PubMed ID: 22328137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.